190 related articles for article (PubMed ID: 8297539)
21. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Cortner JA; Coates PM; Liacouras CA; Jarvik GP
J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
[TBL] [Abstract][Full Text] [Related]
22. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
23. A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia.
Pisciotta L; Fasano T; Calabresi L; Bellocchio A; Fresa R; Borrini C; Calandra S; Bertolini S
Atherosclerosis; 2008 May; 198(1):145-51. PubMed ID: 17950741
[TBL] [Abstract][Full Text] [Related]
24. Evidence for single gene contributions to hypertension and lipid disturbances: definition, genetics, and clinical significance.
Williams RR; Hunt SC; Hopkins PN; Wu LL; Lalouel JM
Clin Genet; 1994 Jul; 46(1 Spec No):80-7. PubMed ID: 7988084
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.
Hopkins PN; Wu LL; Hunt SC; James BC; Vincent GM; Williams RR
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2783-92. PubMed ID: 9409256
[TBL] [Abstract][Full Text] [Related]
26. The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a).
Hegele RA; Sutherland S; Robertson M; Wu L; Emi M; Hopkins PN; Williams RR; Lalouel JM
Clin Invest Med; 1991 Apr; 14(2):146-52. PubMed ID: 1829402
[TBL] [Abstract][Full Text] [Related]
27. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
[TBL] [Abstract][Full Text] [Related]
28. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
[TBL] [Abstract][Full Text] [Related]
29. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease.
Wesolowska E; Marcil M; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Pathol Biol (Paris); 1998 May; 46(5):295-300. PubMed ID: 9769888
[TBL] [Abstract][Full Text] [Related]
31. Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia.
Rader DJ; Schaefer JR; Lohse P; Ikewaki K; Thomas F; Harris WA; Zech LA; Dujovne CA; Brewer HB
Metabolism; 1993 Nov; 42(11):1429-34. PubMed ID: 8231838
[TBL] [Abstract][Full Text] [Related]
32. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility.
Breslow JL
Annu Rev Genet; 2000; 34():233-254. PubMed ID: 11092828
[TBL] [Abstract][Full Text] [Related]
33. Genetic traits related to hypertension and electrolyte metabolism.
Williams RR; Hasstedt SJ; Hunt SC; Wu LL; Hopkins PN; Berry TD; Stults BM; Barlow GK; Kuida H
Hypertension; 1991 Jan; 17(1 Suppl):I69-73. PubMed ID: 1987014
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
35. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
[TBL] [Abstract][Full Text] [Related]
36. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
Raj R; Bhatti JS; Badada SK; Ramteke PW
Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
[TBL] [Abstract][Full Text] [Related]
37. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
Corvol P; Soubrier F; Jeunemaitre X
Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
[TBL] [Abstract][Full Text] [Related]
39. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
[TBL] [Abstract][Full Text] [Related]
40. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
